Michelle L. Sapp, ARNP

Michelle Sapp practices at Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami.

Michelle Sapp's NPI, 1619931136, was assigned on April 13, 2006. Michelle Sapp holds Florida license ARNP3108762.

Michelle Sapp's primary practice is Sylvester Comprehensive Cancer Center, at 1475 Nw 12th Ave, Miami, FL 33136.

Michelle Sapp's primary practice is Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami. The medical group on file is University of Miami Health System.

Dmand AI tracks the electronic health record (EHR) system at each site where Michelle Sapp practices. Vendor and product names are available with a free account.

Nurse practitioner is Michelle Sapp's primary specialty in the NPI Registry, under taxonomy code 363L00000X. Michelle Sapp is licensed in Florida.

Dmand AI lists muscle pain, fibromyalgia, and limb pain and rash among the conditions Michelle Sapp treats.

CMS data shows 44 Medicare services from Michelle Sapp across 1 procedure code in 2024, all of them office visits, for 32 Medicare patients. Medicare paid $2,914 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 32 Medicare patients who saw Michelle Sapp in 2024. The largest group is 65 to 74, with 18 patients. 72% of them have high blood pressure, and 69% have high cholesterol. 44% are also on Medicaid. Their average risk score is 3.55, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Michelle Sapp's median patient age at 65, with 43% women.

In 2024, Michelle Sapp wrote 353 Medicare Part D claims for 57 patients. 75% of them were for generic drugs. CMS names the drug for 168 of them, across 9 drugs with 11 or more claims each, at $202,773 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Michelle Sapp for performance year 2024, reported as part of a group. Michelle Sapp accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Michelle Sapp as offering telehealth.

CMS Open Payments shows 76 general payments to Michelle Sapp from 23 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 94% of the total. Janssen Pharmaceuticals, Inc paid the most, $557.